skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,335  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Material Type:
Article
Add to My Research

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Circulation research, 2020-06, Vol.126 (12), p.1671-1681 [Peer Reviewed Journal]

2020 American Heart Association, Inc. ;2020 The Authors. 2020 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.120.317134 ;PMID: 32302265

Full text available

2
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: To Continue or Stop Preoperatively-the Debate Continues
Material Type:
Article
Add to My Research

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: To Continue or Stop Preoperatively-the Debate Continues

Anesthesia and analgesia, 2024-04, Vol.138 (4), p.760-762 [Peer Reviewed Journal]

EISSN: 1526-7598 ;DOI: 10.1213/ANE.0000000000006825 ;PMID: 38489795

Full text available

3
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19
Material Type:
Article
Add to My Research

Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19

Hypertension research, 2020-07, Vol.43 (7), p.648-654 [Peer Reviewed Journal]

The Japanese Society of Hypertension 2020. ;The Japanese Society of Hypertension 2020 ;ISSN: 0916-9636 ;EISSN: 1348-4214 ;DOI: 10.1038/s41440-020-0455-8 ;PMID: 32341442

Full text available

4
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
Material Type:
Article
Add to My Research

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19

Journal of travel medicine, 2020-05, Vol.27 (3) [Peer Reviewed Journal]

International Society of Travel Medicine 2020. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2020 ;International Society of Travel Medicine 2020. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1195-1982 ;EISSN: 1708-8305 ;DOI: 10.1093/jtm/taaa041 ;PMID: 32186711

Full text available

5
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
Material Type:
Article
Add to My Research

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

The New England journal of medicine, 2008-09, Vol.359 (12), p.1225-1237 [Peer Reviewed Journal]

Copyright © 2008 Massachusetts Medical Society. All rights reserved. ;2008 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2008 Massachusetts Medical Society. All rights reserved. 2008 ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0804593 ;PMID: 18753639 ;CODEN: NEJMAG

Full text available

6
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
Material Type:
Article
Add to My Research

Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF

Circulation (New York, N.Y.), 2020-02, Vol.141 (5), p.338-351 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044491 ;PMID: 31736337

Full text available

7
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
Material Type:
Article
Add to My Research

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?

JAMA, 2020-05, Vol.323 (18), p.1769 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.4812

Digital Resources/Online E-Resources

8
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review
Material Type:
Article
Add to My Research

Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review

Annals of Internal Medicine, 2020-08 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://annals.org/aim/pages/conditions-of-use ;DOI: 10.7326/M20-1515

Digital Resources/Online E-Resources

9
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Material Type:
Article
Add to My Research

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

BMJ (Online), 2018-10, Vol.363, p.k4209 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k4209 ;PMID: 30355745

Full text available

10
Polypill Strategy in Secondary Cardiovascular Prevention
Material Type:
Article
Add to My Research

Polypill Strategy in Secondary Cardiovascular Prevention

The New England journal of medicine, 2022-09, Vol.387 (11), p.967-977 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208275 ;PMID: 36018037

Full text available

11
Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
Material Type:
Article
Add to My Research

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

The New England journal of medicine, 2021-11, Vol.385 (20), p.1845-1855 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2104508 ;PMID: 34758252

Full text available

12
Associations of serum potassium levels with mortality in chronic heart failure patients
Material Type:
Article
Add to My Research

Associations of serum potassium levels with mortality in chronic heart failure patients

European heart journal, 2017-10, Vol.38 (38), p.2890-2896 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehx460 ;PMID: 29019614

Full text available

13
Risks of ACE inhibitor and ARB usage in COVID‐19: evaluating the evidence
Material Type:
Article
Add to My Research

Risks of ACE inhibitor and ARB usage in COVID‐19: evaluating the evidence

Clinical Pharmacology & Therapeutics, 2020-08 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/cpt.1863

Digital Resources/Online E-Resources

14
Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial
Material Type:
Article
Add to My Research

Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial

Intensive care medicine, 2017-11, Vol.43 (11), p.1551-1561 [Peer Reviewed Journal]

The Author(s) 2017 ;Intensive Care Medicine is a copyright of Springer, 2017. ;ISSN: 0342-4642 ;EISSN: 1432-1238 ;DOI: 10.1007/s00134-016-4670-3 ;PMID: 28110412

Full text available

15
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
Material Type:
Article
Add to My Research

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

The New England journal of medicine, 2014-09, Vol.371 (11), p.993-1004 [Peer Reviewed Journal]

Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1409077 ;PMID: 25176015 ;CODEN: NEJMAG

Full text available

16
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study
Material Type:
Article
Add to My Research

Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study

Hypertension (Dallas, Tex. 1979), 2021-09, Vol.78 (3), p.591-603 [Peer Reviewed Journal]

ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.120.16667 ;PMID: 34304580

Full text available

17
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Material Type:
Article
Add to My Research

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

The New England journal of medicine, 2013-11, Vol.369 (20), p.1892-1903 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1303154 ;PMID: 24206457 ;CODEN: NEJMAG

Full text available

18
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Material Type:
Article
Add to My Research

Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors

The New England journal of medicine, 2015-01, Vol.372 (3), p.211-221 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1410853 ;PMID: 25415805

Full text available

19
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome
Material Type:
Article
Add to My Research

Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome

The Journal of infectious diseases, 2020-10, Vol.222 (8), p.1256-1264 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa447 ;PMID: 32702098

Full text available

20
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Material Type:
Article
Add to My Research

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis

The Lancet (British edition), 2019-11, Vol.394 (10211), p.1816-1826 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32317-7 ;PMID: 31668726

Full text available

Results 1 - 20 of 2,335  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,195)

Refine My Results

Creation Date 

From To
  1. Before 1993  (161)
  2. 1993 To 1999  (480)
  3. 2000 To 2006  (536)
  4. 2007 To 2014  (600)
  5. After 2014  (559)
  6. More options open sub menu

Resource Type 

  1. Articles  (2,330)
  2. magazinearticle  (3)
  3. Reports  (1)
  4. Book Chapters  (1)
  5. More options open sub menu

Language 

  1. English  (2,232)
  2. Japanese  (209)
  3. German  (46)
  4. French  (24)
  5. Spanish  (19)
  6. Norwegian  (10)
  7. Portuguese  (10)
  8. Swedish  (8)
  9. Polish  (3)
  10. Italian  (3)
  11. Serbian  (3)
  12. Russian  (1)
  13. Turkish  (1)
  14. Korean  (1)
  15. Chinese  (1)
  16. Croatian  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait